Clinical Trials

Accrual Status
Limit to SWOG Trials

1032 Results

View
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9717

Evaluation of Intravenously Administered Tirapazamine Plus Cisplatin in Cervical Cancer, Phase II.
Research Committee(s)
Gynecologic Cancer
Activated
08-15-1998
Closed
08-15-2000
Closed
Phase
Accrual
75%
Published
SWOG Clinical Trial Number
S9803

The Evaluation of Gemcitabine (Gemzar®) in Resistant and Relapsing Multiple Myeloma, Phase II
Activated
08-15-1998
Closed
12-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9832

Enhancing Well-Being During Breast Cancer Recurrence
Research Committee(s)
Breast Cancer
Activated
07-15-1998
Closed
11-15-2002
Closed
Phase
Accrual
18%
SWOG Clinical Trial Number
S9624

Evaluation of Ifosfamide/Mesna for Aggressive Meningeal Tumors (Malignant Meningioma, Hemangiopericytoma and Primary Nervous System Sarcoma), Phase II Study.
Research Committee(s)
Brain Cancer
Activated
07-01-1998
Closed
10-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9718

A Phase II Trial of Gemcitabine Plus Cisplatin in Patients With Extensive Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
07-01-1998
Closed
06-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9713

A Phase II Trial of Cisplatin/Etoposide and Concurrent, Radiotherapy Followed by Paclitaxel/Carboplatin Consolidation For Limited Stage Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
07-01-1998
Closed
08-01-1999
Open
Phase
SWOG Clinical Trial Number
S9808

Long Term Follow-Up Protocol: An Administrative Tool.
Research Committee(s)
Other
Activated
06-15-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9802

A Phase II Trial of Gemcitabine in Advanced Soft Tissue Sarcomas
Activated
05-01-1998
Closed
03-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9626

A Phase III Trial of Placebo Versus Megestrol Acetate 20 mg/Day Versus Megestrol Acetate 40 mg/Day as Treatment for Symptoms of Ovarian Failure in Women Treated for Breast Cancer
Activated
04-15-1998
Closed
05-01-2000
Closed
Phase
Accrual
49%
Published
SWOG Clinical Trial Number
S9635

A Phase II Trial of 5-fluorouracil Plus 776C85 in Patients With Advanced Resistant Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
04-01-1998
Closed
09-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9801

Evaluation of Gemcitabine - Cisplatin Combination Chemotherapy in Esophageal Carcinoma.
Activated
04-01-1998
Closed
06-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9720

Phase II Trial of Paclitaxel and Carboplatin with Amifostine in Advanced Recurrent or Refractory Endometrial Adenocarcinoma
Research Committee(s)
Gynecologic Cancer
Activated
02-15-1998
Closed
07-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9712

Phase II Trial of Concurrent Carboplatin/VP-16 and Radiation Followed by Paclitaxel (Taxol®) For Poor-Risk Stage III Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
02-15-1998
Closed
06-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9800

A Phase II Pilot Trial of CHOP Followed by Rituximab Chimeric Monoclonal Anti-CD20 Antibody for Treatment of Newly Diagnosed Follicular Non-Hodgkin’s Lymphomas
Research Committee(s)
Lymphoma
Activated
02-15-1998
Closed
11-15-1998
Closed
Phase
Accrual
1%
SWOG Clinical Trial Number
S9631

A Cross-Sectional Study to Estimate the Incidence of Endometrial Pathology in Women Receiving Tamoxifen on SWOG-9313 (INT-0137, CALGB 9394, NCCTG 93-30-51)
Research Committee(s)
Breast Cancer
Activated
02-01-1998
Closed
03-01-2000
Closed
Phase
Accrual
72%
Published
SWOG Clinical Trial Number
S9708

Evaluation of Gemcitabine (Gemzar®) in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Activated
12-01-1997
Closed
03-01-1999
Closed
Phase
Accrual
10%
SWOG Clinical Trial Number
SWOG-9507

A Single Arm Phase II Study to Determine the Safety and Efficacy of 4-HPR N-(4-Hydroxyphenyl) Retinamide for Treating Oral Intraepithelial Neoplasia.
Activated
12-01-1997
Closed
03-01-2000
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
S9701

Phase III Randomized Trial of 12 Months VS 3 Months of Paclitaxel in Patients with Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer Who Attain a Clinically Defined Complete Response (CR) Following Platinum/Paclitaxel-Based Chemotherapy (Intergroup)
Research Committee(s)
Gynecologic Cancer
Activated
11-15-1997
Closed
12-01-2001
Closed
Phase
Accrual
13%
SWOG Clinical Trial Number
S9719

Clonal Hematopoiesis as a Marker of Genetic Damage Pilot Study Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence, Ancillary to S9623
Research Committee(s)
Breast Cancer
Activated
10-15-1997
Closed
02-01-2001
Closed
Phase
Accrual
4%
SWOG Clinical Trial Number
S9702

Detection of Malignant Cells in the Marrow and Peripheral Blood Progenitor Cell Products of Breast Cancer Patients Enrolled on Intergroup Randomized Study S9623
Research Committee(s)
Breast Cancer
Activated
10-01-1997
Closed
07-15-1999